Key result
TREK-1 is a mechanosensitive potassium channel whose altered expression and function are implicated in the pathogenesis of right ventricular outflow tract tachycardia, atrial fibrillation, and MI.
Why the study?
The physiological role of the TREK-1 channel in cardiac function has never been thoroughly investigated, despite potential roles unraveled in pathological conditions.
TREK-1 is a mechanosensitive potassium channel whose heterogeneous expression and remodeling in the heart may play a significant role in arrhythmogenesis during pathological conditions like atrial fibrillation and myocardial infarction, making it a potential therapeutic target.
The TREK-1 channel belongs to the TREK subfamily of two-pore domains channels that are activated by stretch and polyunsaturated fatty acids and inactivated by Protein Kinase A phosphorylation. The activation of this potassium channel must induce a hyperpolarization of the resting membrane potential and a shortening of the action potential duration in neurons and cardiac cells, two phenomena being beneficial for these tissues in pathological situations like ischemia-reperfusion. Surprisingly, the physiological role of TREK-1 in cardiac function has never been thoroughly investigated, very likely because of the lack of a specific inhibitor. However, possible roles have been unraveled in pathological situations such as atrial fibrillation worsened by heart failure, right ventricular outflow tract tachycardia or pulmonary arterial hypertension. The inhomogeneous distribution of TREK-1 channel within the heart reinforces the idea that this stretch-activated potassium channel might play a role in cardiac areas where the mechanical constraints are important and need a particular protection afforded by TREK-1. Consequently, the main purpose of this mini review is to discuss the possible role played by TREK -1 in physiological and pathophysiological conditions and its potential role in mechano-electrical feedback. Improved understanding of the role of TREK-1 in the heart may help the development of promising treatments for challenging cardiac diseases.
No takes yet. Share an insight, caveat, or question.
Béchard et al. (2022) conducted a review in Cardiac arrhythmias and structural heart diseases. TREK-1 channel was evaluated. TREK-1 is a mechanosensitive potassium channel whose altered expression and function are implicated in the pathogenesis of right ventricular outflow tract tachycardia, atrial fibrillation, and MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: